Notícias e Atividades da Xilio Therapeutics

Xilio Therapeutics é uma empresa listada sob o símbolo XLO (US).

Veja o organograma con seus 29 executivos principais

Biografias mais buscadas da Xilio Therapeutics

• Rene Russo, Chief Executive Officer and Director
• Sara Bonstein, Chairman of the Board
• Daniel Curran, Director

Recentes movimentos de executivos em Xilio Therapeutics

• Ben Harshbarger, ingressou na Companhia como Chief Legal Officer  (Notícia publicada em 29 de junho de 2026).
• Christina Rossi, Director, deixou a Companhia  (Notícia publicada em 17 de abril de 2026).
• Cheryl Blanchard, ingressou na Companhia como Director  (Notícia publicada em 17 de abril de 2026).

Criar um alerta
para seguir os movimentos de executivos da Xilio Therapeutics.

Xilio Therapeutics possui 2.430 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Tempus has announced the acquisition of Personalis  (publicado em 20 de julho de 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Xilio Therapeutics

• Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President | Xilio Therapeutics, Inc
• Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference | Xilio Therapeutics, Inc
• Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer | Xilio Therapeutics, Inc
• Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results | Xilio Therapeutics, Inc
• Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference | Xilio Therapeutics, Inc
• News Releases | Xilio Therapeutics, Inc
• Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference | Xilio Therapeutics, Inc
• Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results | Xilio Therapeutics, Inc
• https://xiliotx.com/wp-content/uploads/2021/05/Xilio-Merck-CTCSA-press-release-FINAL.pdf
• Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
• View more press releases Close

Redes sociais sobre Xilio Therapeutics

• Xilio Therapeutics na Wikipedia, Google News e Yahoo Finance
• Xilio Therapeutics na LinkedIn, X (Twitter) e YouTube